Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants
- PMID: 9269056
- DOI: 10.1016/s0264-410x(97)00001-7
Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants
Abstract
The low efficiency of trivalent oral polio vaccine (TOPV) in inducing protective antibody titres to polio3 is a problem of great importance in many regions of the world. A prospective study was conducted in 121 Tunisian infants aged 3 months during routine immunization with TOPV under carefully controlled conditions. Seroconversion rates to polio1, polio2 and polio3, one month after the third dose, were 94.7, 100 and 89.5%, respectively. The kinetics of the antibody response showed delayed and more difficult responses to polio3 compared to polio2 and polio1. The following host related factors, previously suggested to interfere with the immune response, were assessed: maternal antibodies; breast-feeding; concurrent enteric infections; and other illnesses. The main factor associated with the lack of seroconversion was concurrent infection with non-polio enteroviruses (NPE) which was found in 50% of non-responders to polio1 and/or to polio3 during the vaccination protocol whereas no NPE was isolated in vaccine responders. The other studied factors seemed not to interfere in the infants according to the locally adopted vaccination schedule and to the specific socio-economic conditions.
Similar articles
-
Antibody response to three doses of standard and double dose of trivalent oral polio vaccine.Indian Pediatr. 1991 Oct;28(10):1141-5. Indian Pediatr. 1991. PMID: 1665840
-
Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.Hum Vaccin Immunother. 2017 Jun 3;13(6):1-10. doi: 10.1080/21645515.2017.1288769. Epub 2017 Mar 1. Hum Vaccin Immunother. 2017. PMID: 28362135 Free PMC article. Clinical Trial.
-
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26. Lancet Infect Dis. 2015. PMID: 26318714 Clinical Trial.
-
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review.Rev Infect Dis. 1991 Sep-Oct;13(5):926-39. doi: 10.1093/clinids/13.5.926. Rev Infect Dis. 1991. PMID: 1660184 Review.
-
Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines.J Infect Dis. 1996 Sep;174 Suppl 1:S107-11. doi: 10.1093/infdis/174.supplement_1.s107. J Infect Dis. 1996. PMID: 8752299 Review.
Cited by
-
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein Microarrays.Vaccines (Basel). 2023 Nov 7;11(11):1694. doi: 10.3390/vaccines11111694. Vaccines (Basel). 2023. PMID: 38006026 Free PMC article.
-
Effect of bovine lactoferrin on seroconversion following polio vaccine administration in children: protocol for a double-blinded randomised controlled trial.BMJ Open. 2022 May 24;12(5):e050849. doi: 10.1136/bmjopen-2021-050849. BMJ Open. 2022. PMID: 35613782 Free PMC article.
-
Factors That Influence the Immune Response to Vaccination.Clin Microbiol Rev. 2019 Mar 13;32(2):e00084-18. doi: 10.1128/CMR.00084-18. Print 2019 Mar 20. Clin Microbiol Rev. 2019. PMID: 30867162 Free PMC article. Review.
-
Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants.Trans R Soc Trop Med Hyg. 2019 Mar 1;113(3):110-115. doi: 10.1093/trstmh/try126. Trans R Soc Trop Med Hyg. 2019. PMID: 30576507 Free PMC article. Clinical Trial.
-
Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting.BMC Cancer. 2018 May 11;18(1):557. doi: 10.1186/s12885-018-4382-x. BMC Cancer. 2018. PMID: 29751793 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources